Wenqiang Gan

State Key Laboratory Of Digestive Health, Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, 100050, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Identification of PLXNC1 as a novel biomarker for consensus molecular subtype 4 in colorectal cancer.

Identification of PLXNC1 as a novel biomarker for consensus molecular subtype 4 in colorectal cancer.

Journal: Genes & diseases

Published: July 11, 2024

Corrigendum to "Spatially resolved metabolomics combined with multicellular tumor spheroids to discover cancer tissue relevant metabolic signatures" [Anal. Chim. Acta 1155 (2021) 338342].

Corrigendum to "Spatially resolved metabolomics combined with multicellular tumor spheroids to discover cancer tissue relevant metabolic signatures" [Anal. Chim. Acta 1155 (2021) 338342].

Journal: Analytica chimica acta

Published: June 15, 2024

Integrated analysis reveals a novel 5-fluorouracil resistance-based prognostic signature with promising implications for predicting the efficacy of chemotherapy and immunotherapy in patients with colorectal cancer.

Integrated analysis reveals a novel 5-fluorouracil resistance-based prognostic signature with promising implications for predicting the efficacy of chemotherapy and immunotherapy in patients with colorectal cancer.

Journal: Apoptosis : an international journal on programmed cell death

Published: May 14, 2024

Taking advantage of the interaction between the sulfoxide and heme cofactor to develop indoleamine 2, 3-dioxygenase 1 inhibitors.

Taking advantage of the interaction between the sulfoxide and heme cofactor to develop indoleamine 2, 3-dioxygenase 1 inhibitors.

Journal: Bioorganic chemistry

Published: February 22, 2024

Identification of immune-related genes and small-molecule drugs in hypertension-induced left ventricular hypertrophy based on machine learning algorithms and molecular docking.

Identification of immune-related genes and small-molecule drugs in hypertension-induced left ventricular hypertrophy based on machine learning algorithms and molecular docking.

Journal: Frontiers in immunology

Published: December 07, 2023

Computational identification and clinical validation of a novel risk signature based on coagulation-related lncRNAs for predicting prognosis, immunotherapy response, and chemosensitivity in colorectal cancer patients.

Computational identification and clinical validation of a novel risk signature based on coagulation-related lncRNAs for predicting prognosis, immunotherapy response, and chemosensitivity in colorectal cancer patients.

Journal: Frontiers in immunology

Published: August 18, 2023

Developing an m5C regulator-mediated RNA methylation modification signature to predict prognosis and immunotherapy efficacy in rectal cancer.

Developing an m5C regulator-mediated RNA methylation modification signature to predict prognosis and immunotherapy efficacy in rectal cancer.

Journal: Frontiers in immunology

Published: September 27, 2022

Characterization of sialylation-related long noncoding RNAs to develop a novel signature for predicting prognosis, immune landscape, and chemotherapy response in colorectal cancer.

Characterization of sialylation-related long noncoding RNAs to develop a novel signature for predicting prognosis, immune landscape, and chemotherapy response in colorectal cancer.

Journal: Frontiers in immunology

Published: July 15, 2022

Comprehensive Analysis of a Cancer-Immunity Cycle-Based Signature for Predicting Prognosis and Immunotherapy Response in Patients With Colorectal Cancer.

Comprehensive Analysis of a Cancer-Immunity Cycle-Based Signature for Predicting Prognosis and Immunotherapy Response in Patients With Colorectal Cancer.

Journal: Frontiers in immunology

Published: March 09, 2022

Prognostic Values and Underlying Regulatory Network of Cohesin Subunits in Esophageal Carcinoma.

Prognostic Values and Underlying Regulatory Network of Cohesin Subunits in Esophageal Carcinoma.

Journal: Journal of Cancer

Published: September 09, 2021

Comprehensive bioinformatics analysis identifies LAPTM5 as a potential blood biomarker for hypertensive patients with left ventricular hypertrophy.

Comprehensive bioinformatics analysis identifies LAPTM5 as a potential blood biomarker for hypertensive patients with left ventricular hypertrophy.

Journal: Aging

Published: August 10, 2021

SEMA6B Overexpression Predicts Poor Prognosis and Correlates With the Tumor Immunosuppressive Microenvironment in Colorectal Cancer.

SEMA6B Overexpression Predicts Poor Prognosis and Correlates With the Tumor Immunosuppressive Microenvironment in Colorectal Cancer.

Journal: Frontiers in molecular biosciences

Published: March 29, 2021

Showing 1-12 of 21

Last Updated: 09/26/2026